Breaking News
EG4 Power Pro VS Ruixu Lithi VS Yixiang Budget Battery! Best Selling Battery Showdown!
When Society Breaks: The Human Threats You'll Face in a Real SHTF Collapse
Dubai-Based Emirates Airline Adds Bitcoin and Crypto Payments
Oh My F#@!ing God, They're Doing It Again
Top Tech News
What could possibly go wrong? Scientists use AI to design new viruses
Dual-motor suitcase drive underpins 3,000-hp hypercar
DoorDash Wins Federal Approval To Fly Its Own Delivery Drones
Shade-Resistant Solar Cells Retain 97% Efficiency After 2,000 Hours of Testing
20 Ancient Engineering SECRETS
Stonehenge Was Reanalyzed by AI -- And the Findings Are Hard to Explain
After Years Of Delays, Aptera Is Finally Preparing To Build Customer Cars
'When you kill it, it doesn't die': the jellyfish that has cracked the secret of immorta
Archer Aviation debuts Halo autonomous VTOL, Thunder's commercial twin
US Telecoms Slide On Starlink Mobile Threat; Bernstein Sees It As A "Jab, But No Knockout Yet**
When Placebos are Not Inert
As recently as May 1, 2025, the Secretary of HHS, Robert F. Kennedy Jr., instituted a requirement that all new vaccines are to be tested against an inert substance known as a placebo before they can be made available, which represents a "radical departure from past practices."
Most Americans, and indeed most consumers worldwide, understand that a placebo is a substance that is not biologically active and is completely inert. It is used to identify the number and type of adverse reactions that may occur compared to the test substance. In other words, a genuinely harmless substance is employed to assess the safety of the new drug or vaccine being introduced to the market.
As early as 2002, vaccine researchers raised questions about randomized, placebo-controlled trial design, highlighting ethical concerns regarding the participants in the control arm. Were they being deprived of "the benefits" of an existing vaccine? Furthermore, they challenged the scientific standard by questioning the gold-standard study hypothesis: Is an experimental vaccine more efficacious than one already in use?